X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 54 filers reported holding X4 PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,163,785 | -43.0% | 1,067,693 | +1.5% | 0.00% | – |
| Q2 2023 | $2,040,694 | +945.0% | 1,051,904 | +368.6% | 0.00% | – |
| Q1 2023 | $195,289 | +34.0% | 224,470 | +53.0% | 0.00% | – |
| Q4 2022 | $145,686 | -0.2% | 146,713 | +72.2% | 0.00% | – |
| Q3 2022 | $146,000 | +170.4% | 85,187 | +52.7% | 0.00% | – |
| Q2 2022 | $54,000 | -44.3% | 55,776 | +0.6% | 0.00% | – |
| Q1 2022 | $97,000 | -37.4% | 55,426 | -17.9% | 0.00% | – |
| Q4 2021 | $155,000 | -56.8% | 67,504 | -0.5% | 0.00% | – |
| Q3 2021 | $359,000 | -19.5% | 67,859 | -1.0% | 0.00% | – |
| Q2 2021 | $446,000 | -71.3% | 68,563 | -62.0% | 0.00% | – |
| Q1 2021 | $1,553,000 | +16.1% | 180,382 | -13.3% | 0.00% | – |
| Q4 2020 | $1,338,000 | -14.5% | 207,983 | -10.0% | 0.00% | – |
| Q3 2020 | $1,565,000 | -30.3% | 231,035 | -4.1% | 0.00% | -100.0% |
| Q2 2020 | $2,246,000 | +22.3% | 240,945 | +31.3% | 0.00% | 0.0% |
| Q1 2020 | $1,836,000 | +23.0% | 183,574 | +31.6% | 0.00% | – |
| Q4 2019 | $1,493,000 | +2.9% | 139,455 | +22.1% | 0.00% | – |
| Q3 2019 | $1,451,000 | +270.2% | 114,168 | +337.7% | 0.00% | – |
| Q2 2019 | $392,000 | – | 26,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |